2nd COVID-19 vaccine by Moderna set for FDA approval in US after panel endorsement
By MATTHEW PERRONE and LAURAN NEERGAARD
Published article
In this photo illustration a medical syringe and a vial depicting fake coronavirus vaccine seen in front of the Moderna US biotechnology company logo. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)
WASHINGTON - A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
AP
TribLIVE s Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.
WASHINGTON A government advisory panel endorsed a second covid-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
The FDA’s green light for emergency use is expected quickly. Moderna would then begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
Panel Endorses Second COVID-19 Vaccine, Paving Way For FDA Approval
A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants.
Maddie Meyer/Getty Images
December 17, 2020
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
FDA vows quick approval of Moderna coronavirus vaccine after key vote
A Food and Drug Administration panel of advisers voted 20-0 to endorse Modernaâs version of the vaccine.
Â
Â
A nurse prepares a shot as a study of a COVID-19 vaccine developed by the National Institutes of Health and Moderna Inc. [ HANS PENNINK | AP ]
Updated Dec. 18, 2020
WASHINGTON â The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.
Image via AP Photo/Hans Pennink
This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.
WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign. The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up. The FDA’s green…